LLC KONSORTSIUM PIK has a total of 12 patent applications. Its first patent ever was published in 2013. It filed its patents most often in Australia, Canada and EAPO (Eurasian Patent Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are LEUKOS BIOTECH S L, LIU BAOSHUN and PRIMUS PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Canada | 2 | |
#3 | EAPO (Eurasian Patent Organization) | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | United States | 2 | |
#6 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Medical purpose containers |
# | Name | Total Patents |
---|---|---|
#1 | Noskov Dmitriy Sergeevich | 6 |
#2 | Khmelshchikov Yuri Vladimirovich | 6 |
#3 | Nikiforov Aleksandr Sergeevich | 5 |
#4 | Kim Galina Aleksandrovna | 5 |
#5 | Bykov Vladimir Nikolaevich | 4 |
#6 | Vladimir Nikolaevich Bykov | 1 |
#7 | Galina Aleksandrovna Kim | 1 |
#8 | Aleksandr Sergeevich Nikiforov | 1 |
#9 | Bykov Vladamir Nikolaevich | 1 |
Publication | Filing date | Title |
---|---|---|
US2019381003A1 | Pharmaceutical composition for treatment of inflammatory ear diseases, method for producing same and method for treatment using same composition | |
EP3165223A1 | Use of 3-(3-[1,2,4]-triazolo)-oxatriazolium-5-olate for treating sexual disorders | |
AU2015384252A1 | Pharmaceutical composition for treatment of inflammatory ear diseases, method for producing same and method for treatment using said composition |